MicroBase Technology Corp. (TPEX:3184)

Market Cap	1.10B +36.9%
Revenue (ttm)	210.93M -2.9%
Net Income	43.68M -8.6%
EPS	0.69 -7.4%
Shares Out	63.07M
PE Ratio	25.12
Forward PE	n/a
Dividend	0.22 (1.27%)
Ex-Dividend Date	Jul 13, 2026

Volume	157,960
Open	18.10
Previous Close	18.05
Day's Range	17.35 - 18.25
52-Week Range	8.40 - 35.90
Beta	0.61
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About MicroBase Technology

MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, Pocket Air, an aerosol drug delivery solution; and soluble and insoluble microneedles. MicroBase Technology Corp. was founded in 1997 and is based in Taoyu...

• Industry: Electronic Components
• Sector: Technology
• Founded: 1997
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3184

Financial Performance

In 2025, MicroBase Technology's revenue was 211.70 million, a decrease of -1.43% compared to the previous year's 214.76 million. Earnings were 30.14 million, a decrease of -56.59%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error